🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📢Genetic Counselors & healthcare providers! Register for our upcoming webinar and learn about #cfDNA technology over time and its current applications in the #prenatal, #oncology, and #transplant setting. #Natera Genetic Counselors #NSGC #CEU #GC ow.ly/MtgX50VU1nP

ASCO is one of the most important oncology meetings of the year, and together with our collaborators, Natera will share Signatera data from 25+ presentations across 10 different types of cancer. This includes: • Breast cancer: 8 accepted abstracts (4 oral presentations) •

Join our webinar, Implementing Prospera - Advantages of our Natera Concierge Program, to learn more about: • Common questions when switching brands or starting a new workflow • Resources Natera can provide to your team • Our Natera Concierge Team 👉ow.ly/CqKl50VY2Yy

Big thanks to Natera for donating these care kits to Veterans who were staying at our hospital over the Memorial Day weekend. Today and every day we remember those who made the ultimate sacrifice for this country!

Listen now 🎧 Genetics in Kidney Care: Time to Act This podcast ep features Ronen Schneider, M.D., medical director, renal genetics at #Natera, exploring the connection between genetics and kidney health. Hear the full episode: ow.ly/UpEv50VZtma #Renasight @ASNpublications

Join our webinar, Implementing Prospera - Advantages of our Natera Concierge Program, to learn more about: • Common questions when switching brands or starting a new workflow • Resources Natera can provide to your team • Our Natera Concierge Team 👉ow.ly/Xy0050VY38t

We're looking forward to ASCO 2025! Be sure to catch our 25+ abstracts and 4 oral presentations. 📊🧬 Join us at booth #13080 to meet our team and learn more! See below for details. ow.ly/AWJo50VZBm7 #ASCO25 #Natera ASCO

Register for our upcoming webinar focusing on the dynamic role of the MSL, a field-based role supporting healthcare providers offering #GeneticTesting. Meet a panel of GC's currently working in the areas of Organ Health, Women’s Health & Oncology. ow.ly/Bvf650W0hfs #Natera

In this Oncology Times podcast, Dr. Ruchika Talwar and #Natera’s Dr. @Oncojurdi explore the role of tumor-informed MRD testing in guiding real-time decisions and earlier detection. 🎧 Listen here: ow.ly/svgu50W0Ti3 ASCO #ASCO25

Learn more about Signatera and the foundational technology that is transforming care for patients with cancer. Hear directly from Natera CEO Steve Chapman on how Signatera can detect molecular residual disease and help determine whether therapy is working. #CancerCare

👋Hello from ASCO 2025! Stop by our booth #13080 to learn more about our latest data. Be sure to catch our 30+ abstracts and oral presentations. 📊🧬 See below for details. ow.ly/rhxV50W1Osv #ASCO25 #Natera ASCO

Attending #ASCO25? Stop by booth #13080 to learn more about our expanding body of data in solid tumor malignancies and speak to our team!👋 📊🧬 ow.ly/3miK50W217z #ASCO25 #Natera ASCO

It’s a time to celebrate life, share hope, and recognize the incredible strength of those living with and beyond cancer. Whether you’re reflecting on your own survivorship or standing beside a loved one, today is about connection, resilience, and community. At Natera, we’re

Don't miss our presentation at 3 PM CT 📊🧬Predicting nodal burden after neoadjuvant chemotherapy (NAC) w/ (ct)DNA for surgical planning: Results from the I-SPY2 trial. Presenter by: Rita Mukhtar, MD Click here for full details: ow.ly/y2X050W2QYy #ASCO25 #Natera ASCO

We’re pleased to announce that our genome-based Signatera MRD assay is now covered by Medicare. This coverage applies to patients with colorectal, breast, bladder, ovarian, and lung cancers, as well as those receiving pan-cancer immunotherapy monitoring—extending access across a

Join the upcoming webinar, Illuminating the #CKD patient journey: Clinicogenomic data reshapes research & drug discovery, on June 18! Register today👉 ow.ly/wEMR50W47bk